Physician profile
Txong Her
NPI 1932417722
$1,074.84
in general payments reported to CMS, 2019-2025
17 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.14 · 2023: $359 · 2024: $407 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $144.03 | 2023-2024 | Repatha, Otezla |
| Neurocrine Biosciences, INC. | $139.77 | 2024 | Ingrezza |
| Regeneron Healthcare Solutions, INC. | $130.99 | 2024-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Abbvie INC. | $124.99 | 2023 | |
| Lilly USA, LLC | $87.55 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $50.19 | 2024-2025 | Wegovy, Rybelsus |
| Exact Sciences Corporation | $47.12 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $34.52 | 2025 | |
| Axsome Therapeutics, INC. | $34.27 | 2024-2025 | Auvelity |
| Dynavax Technologies Corporation | $30.58 | 2023 | Heplisav-B |
| Corium, LLC | $29.35 | 2024 | Azstarys |
| Hologic Sales and Service, LLC | $24.63 | 2023 | Third Wave |
| Abbott Laboratories | $22.52 | 2023 | Freestyle Libre 3 |
| Pfizer INC. | $20.47 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.72 | 2023 | Bexsero, Shingrix, Arexvy |
| Organon LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Txong Her listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.